Literature DB >> 31679811

Parotid secretory carcinoma with high-grade transformation.

Yuki Numano1, Takenori Ogawa2, Tomohiko Ishikawa1, Hajime Usubuchi3, Ayako Nakanome1, Akira Ohkoshi1, Eiichi Ishida1, Masahiro Rokugo1, Yukio Katori1.   

Abstract

Here we present a patient with a parotid secretory carcinoma (SC) with high-grade transformation. A 65-year-old female was referred to our hospital due to a gradually growing right parotid tumor discovered initially about 4 years earlier. MRI imaging detected a right parotid tumor 50 mm in the longer axis. Fine needle aspiration cytology indicated a class III tumor. Nine months after her initial visit, she revisited our department because of pain, trismus and facial paralysis. MRI detected a tumor 69 mm in the longer axis and 64 mm in the shorter axis and a biopsy specimen revealed parotid cancer. Furthermore, positron emission tomography revealed a synchronous small cell lung cancer (SCLC). Chemoradiotherapy for the SCLC was performed followed by an extended total parotidectomy for the parotid SC. Histological findings and ETV6-FISH analysis confirmed a parotid SC with high-grade transformation. Two months after the surgery, CT revealed a loco-regional recurrence and proton beam therapy (70.2 GyE/26 Fr) was performed. Three months after the proton beam therapy, CT indicated pleural effusion and lung metastasis, and fine needle aspiration cytology revealed the metastatic SC. Eight months after the surgery, the patient died due to the lung metastasis of SC.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  High-grade transformation; Parotid cancer; Pathology; Secretory carcinoma

Year:  2019        PMID: 31679811     DOI: 10.1016/j.anl.2019.10.003

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  3 in total

1.  A retrospective study of parotid gland tumors at a single institution.

Authors:  Shiori Suzuki; Nobuyuki Bandoh; Takashi Goto; Akinobu Kubota; Akihiro Uemura; Michihisa Kono; Ryosuke Sato; Ryuhei Takeda; Shota Sakaue; Tomomi Yamaguchi-Isochi; Hiroshi Nishihara; Hidehiro Takei; Yasuaki Harabuchi
Journal:  Oncol Lett       Date:  2022-05-13       Impact factor: 3.111

2.  Clinicopathological investigation of secretory carcinoma cases including a successful treatment outcome using entrectinib for high-grade transformation: a case report.

Authors:  Kensuke Suzuki; Hiroshi Harada; Masayuki Takeda; Chisato Ohe; Yoshiko Uemura; Akihiko Kawahara; Shunsuke Sawada; Akira Kanda; Bhaswati Sengupta; Hiroshi Iwai
Journal:  BMC Med Genomics       Date:  2022-01-06       Impact factor: 3.063

3.  Single nucleotide polymorphisms in tinnitus patients exhibiting severe distress.

Authors:  Takahisa Watabe; Sho Kanzaki; Noriko Sato; Tatsuo Matsunaga; Masaaki Muramatsu; Kaoru Ogawa
Journal:  Sci Rep       Date:  2020-08-03       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.